RBM15 is a novel prognostic biomarker and correlates with immune cell infiltration in lung adenocarcinoma
Abstract Background and aims This study aimed to evaluate RBM15 gene expression and the potential effects as a biomarker in LUAD progression. Materials and methods The RNA sequencing (RNA-seq) data and clinical data of patients with LUAD were acquired from The Cancer Genome Atlas (TCGA) databases. K...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BMC
2025-10-01
|
| سلاسل: | Journal of Cardiothoracic Surgery |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s13019-025-03585-6 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|